Clinical trial Recruiting at 1 site Interventional Ages 20 and up

Evaluating heart imaging techniques for coronary disease treatment

Official title: Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial: Ischemia-guided Revascularization Using Perfusion Coronary CT vs. Fractional Flow Reserve

Run by Asan Medical Center · NCT02208388 · Data updated 2026-11-12

This study is testing whether using a specific heart imaging technique called computed tomography perfusion can help people with coronary artery disease get better treatment results compared to another method called fractional flow reserve.

Quick facts

Study typeInterventional
Ages20 Years and up
SexAll
Enrollment1000 (estimated)
SponsorAsan Medical Center
Academic / other
Locations7 sites (Seoul, Songpa-Gu and 6 other locations)
StatusRecruiting
StartedAugust 12, 2014
Main results expectedMarch 5, 2028
Study endsMarch 5, 2028
Registry record updatedApril 5, 2023
Trial IDNCT02208388 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 20 and older with diagnosed angina or equivalent symptoms and significant coronary artery stenosis.

Probably not a fit

Patients requiring surgical procedures or those with severe heart conditions or other significant health issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the safety and effectiveness of computed tomography perfusion (CTP) guided revascularization compared to fractional flow reserve (FFR) guided revascularization in patients with coronary artery disease. Participants will be evaluated based on their symptoms and the severity of their coronary artery blockages. The study will include patients aged 20 and older who meet specific criteria related to their heart condition and will exclude those with certain severe health issues. The goal is to determine which imaging technique provides better outcomes for patients undergoing treatment.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies for patients with coronary artery disease, enhancing their recovery and quality of life.

How similar studies have gone: Previous studies have shown promising results with similar imaging techniques in guiding coronary interventions, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 20 and more
* Diagnosed angina or angina equivalent symptom or positive exercise treadmill test
* Patients with intermediate- or high-risk probability of CAD defined by Diamond and Forester
* 70 % stenosis or more in coronary CTA
* Willing to provide informed, written consent

Exclusion Criteria:

* Requirement for surgical procedure
* Cardiogenic shock and/or need for mechanical/pharmacologic hemodynamic support
* Recent STEMI (\<5 days)
* Non STEMI, if the cardiac troponin is not stable or starting to decline
* Left ventricular ejection fraction \<30%
* Life expectancy \<2 years
* Impaired renal function with an effective glomerular filtration rate less than 30mL/min/1.73 ㎡ or creatinine more than 2.0 mg/dL
* Undergoing evaluation for organ transplantation
* Participation or planned participation in another cardiovascular clinical trial
* Pregnancy
* Inability to take dual antiplatelet therapy for six months
* Previous CABG
* Left main disease requiring revascularization
* Any target lesion with in-stent restenosis
* NYHA class 3 or 4a
* Severe and persistent angina with severe limitation in everyday living activities (Canadian Cardiovascular Society grading Class IV)

Where it's running

  • Asan Medical Center
    Seoul, Songpa-Gu, South Korea
    Recruiting
  • Hallym University Sacred Heart Hospital
    Anyang, South Korea
    Completed
  • Gangwon National Univ. Hospital
    Chuncheon, South Korea
    Completed
  • Keimyung University Dongsan Medical Center
    Daegu, South Korea
    Completed
  • Pusan National University Hospital
    Pusan, South Korea
    Enrolling by invitation
  • Pusan National University Yangsan Hospital
    Pusan, South Korea
    Completed
Show 1 more location
  • Severance Hospital
    Seoul, South Korea
    Withdrawn

Study contacts

  • Principal investigator: Byoung-Wook Choi, MD — Severance Hospital
  • Study coordinator: Young-Hak Kim, MD
  • Email: mdyhkim@amc.seoul.kr

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.